YKL-40 levels are independently associated with albuminuria in type 2 diabetes
- PMID: 21696606
- PMCID: PMC3144447
- DOI: 10.1186/1475-2840-10-54
YKL-40 levels are independently associated with albuminuria in type 2 diabetes
Abstract
Objective and design: YKL-40 is involved in inflammation and endothelial dysfunction, and is increased in patients with type 1 diabetes, with an independent association between increasing YKL-40 levels and increasing levels of albuminuria. YKL-40 is associated with atherosclerosis and an increased cardiovascular mortality in the general population. In the present study YKL-40 levels were examined in patients with type 2 diabetes (T2D) with increasing levels of albuminuria, known to be associated with an increased risk of cardiovascular disease.
Materials and methods: One-hundred-five patients with T2D were examined: 49 with normoalbuminuria (N, U-albumin/creatinine < 2.5 mg/mmol), 35 with persistent microalbuminuria (MA, 2.5-25 mg/mmol) and 21 with persistent macroalbuminuria/diabetic nephropathy (DN, > 25 mg/mmol). The control group consisted of 20 healthy individuals (C). Groups were matched according to age, gender and known duration of diabetes.
Results: Median levels (interquartile range) of serum YKL-40 were significantly higher in N and MA vs. C (86 (55-137) ng/ml and 84 (71-147) ng/ml, respectively vs. 41 (33-55) ng/ml, p < 0.01) and even higher in patients with DN (120 (83-220) ng/ml, p < 0.001 for all comparisons). YKL-40 levels correlated with urinary albumin/creatinine-ratio in the total group of participants (r = 0.41, p < 0.001). Significant intercorrelations of YKL-40 were found with age, duration of diabetes, systolic blood pressure, lipid levels, HbA1c and HOMA-IR. After adjustment for significant covariates, albuminuria was significantly associated with YKL-40 levels (r = 0.32, p = 0.006).
Conclusions: YKL-40 levels are elevated in patients with T2D with an independent association between increasing YKL-40 levels and increasing levels of albuminuria. The study suggests a role of YKL-40 in the progressing vascular complications in patients with T2D.
Figures
Similar articles
-
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.Diabetes Care. 2009 Feb;32(2):323-8. doi: 10.2337/dc08-1144. Epub 2008 Oct 28. Diabetes Care. 2009. PMID: 18957531 Free PMC article.
-
High YKL-40 levels predict mortality in patients with type 2 diabetes.Diabetes Res Clin Pract. 2012 Apr;96(1):84-9. doi: 10.1016/j.diabres.2011.12.008. Epub 2011 Dec 31. Diabetes Res Clin Pract. 2012. PMID: 22209020
-
YKL-40 in type 2 diabetic patients with different levels of albuminuria.Eur J Clin Invest. 2011 Jun;41(6):589-96. doi: 10.1111/j.1365-2362.2010.02446.x. Epub 2010 Dec 16. Eur J Clin Invest. 2011. PMID: 21158852
-
Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients.J Diabetes Complications. 2012 Jul-Aug;26(4):308-12. doi: 10.1016/j.jdiacomp.2012.04.012. Epub 2012 Jun 15. J Diabetes Complications. 2012. PMID: 22705282
-
YKL-40--an emerging biomarker in cardiovascular disease and diabetes.Cardiovasc Diabetol. 2009 Nov 23;8:61. doi: 10.1186/1475-2840-8-61. Cardiovasc Diabetol. 2009. PMID: 19930630 Free PMC article. Review.
Cited by
-
Myokines: Novel therapeutic targets for diabetic nephropathy.Front Endocrinol (Lausanne). 2022 Oct 25;13:1014581. doi: 10.3389/fendo.2022.1014581. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387916 Free PMC article. Review.
-
The Value of Serum YKL-40 and TNF-α in the Diagnosis of Acute ST-Segment Elevation Myocardial Infarction.Cardiol Res Pract. 2022 Aug 23;2022:4905954. doi: 10.1155/2022/4905954. eCollection 2022. Cardiol Res Pract. 2022. PMID: 36051575 Free PMC article.
-
Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis.Diabetol Metab Syndr. 2021 Jan 15;13(1):6. doi: 10.1186/s13098-021-00624-9. Diabetol Metab Syndr. 2021. PMID: 33446257 Free PMC article.
-
Diagnostic Performance of Biomarkers Urinary KIM-1 and YKL-40 for Early Diabetic Nephropathy, in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2020 Nov 7;10(11):909. doi: 10.3390/diagnostics10110909. Diagnostics (Basel). 2020. PMID: 33171707 Free PMC article.
-
Chitinase-3 like-protein-1 function and its role in diseases.Signal Transduct Target Ther. 2020 Sep 14;5(1):201. doi: 10.1038/s41392-020-00303-7. Signal Transduct Target Ther. 2020. PMID: 32929074 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
